Notice Announcing the Systems Biology Data Platform Leveraging the Accelerating Medicines Partnership (OT2)
Notice NOT-RM-24-008 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 18, 2024 Category: Research Source Type: funding

Notice Announcing Publication of Development and Application of Ophthalmic Imaging Technologies to Advance Our Understanding of Systemic Diseases (OT2) Research Opportunity Announcement
Notice NOT-RM-24-007 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 18, 2024 Category: Research Source Type: funding

Mechanisms of Cognitive Fluctuations in ADRD Populations (R01 - Clinical Trial Optional)
Funding Opportunity RFA-NS-25-014 from the NIH Guide for Grants and Contracts. "Fluctuating cognition can occur in many types of dementia and is a core clinical feature of Dementia with Lewy Bodies. Cognitive fluctuations can last from seconds to days, are unpredictable (e.g., do not just occur in the evenings, as with sun-downing), and are associated with poor daily functioning for the patient. A number of small studies have suggested that cognitive fluctuations in subjects with dementia may be related to epileptiform discharges and impaired oscillatory activity on EEG, but it is not clear that these are the only facto...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 18, 2024 Category: Research Source Type: funding

Notice of Special Interest (NOSI): Administrative Supplements for Assessing and Enhancing Survivorship Care
Notice NOT-CA-24-035 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 15, 2024 Category: Research Source Type: funding

Notice of Intent to Publish a Funding Opportunity Announcement for The Road to Prevention of Stillbirth (UM2 Clinical Trial Not Allowed)
Notice NOT-HD-24-010 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 15, 2024 Category: Research Source Type: funding

Notice of Intent to Publish a Funding Opportunity Announcement for The Road to Prevention of Stillbirth (UG1 Clinical Trial Optional)
Notice NOT-HD-24-009 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 15, 2024 Category: Research Source Type: funding

Notice of Pre-Application Webinar for RFA-AG-25-005: Open Measurement Coordinating Network for Non-Pharmacological Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Primary Prevention Trials (U24 Clinical Trial Not Allowed)
Notice NOT-AG-24-007 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 15, 2024 Category: Research Source Type: funding

Notice of Intent to Publish a Funding Opportunity Announcement for Research to Advance the Science of Primary Care (R01)
Notice NOT-HS-24-010 from the NIH Guide for Grants and Contracts (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 15, 2024 Category: Research Source Type: funding

Research on the Neuro-Immune Axis in the Context of HIV and Substance Use (R21 Clinical Trial Not Allowed)
Funding Opportunity RFA-DA-25-005 from the NIH Guide for Grants and Contracts. The purpose of this notice of funding opportunity (NOFO) is to support research towards identifying and characterizing neuroimmune networks, communication pathways, and targets that reside within neuroimmune axes, in the context of HIV and substance use. This NOFO will also support research on the discovery of novel modulatory probes/tools that can advance our knowledge of the regulatory mechanisms by which neuroimmune interactions contribute to HIV and substance use disorder comorbidity. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 14, 2024 Category: Research Source Type: funding

Research on the Neuro-Immune Axis in the context of HIV and Substance Use (R01 Clinical Trial Not Allowed)
Funding Opportunity RFA-DA-25-004 from the NIH Guide for Grants and Contracts. The purpose of this notice of funding opportunity (NOFO) is to support research towards identifying and characterizing neuroimmune networks, communication pathways, and targets that reside within neuroimmune axes, in the context of HIV and substance use. This NOFO will also support research on the discovery of novel modulatory probes/tools that can advance our understanding of the regulatory mechanisms by which neuroimmune interactions contribute to HIV and substance use disorder comorbidity. (Source: NIH Funding Opportunities (Notices, PA, RFA))
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 14, 2024 Category: Research Source Type: funding

Botanical Dietary Supplements Translational Research Teams (RM1 Clinical Trial Required)
Funding Opportunity RFA-OD-24-014 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to support collaborative, transdisciplinary, translational research projects which advance exceptionally promising, chemically complex botanical and other natural products relevant to dietary supplements towards highly informative clinical trials of their effects on quantitative, objective measures of human resilience. Dynamic, synergistic interactions among the range of experts required to ensure rigor in all aspects of this research will be supported by a multi-PD/PI team collabora...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 14, 2024 Category: Research Source Type: funding

Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed)
Funding Opportunity PAR-24-145 from the NIH Guide for Grants and Contracts. The SuRE program supports research capacity building at eligible higher education institutions through funding investigator-initiated biomedical research inbasic, social, clinical, behavioral, or translational science that falls in the mission areas of the NIH. The purpose of SuRE-First awards is to provide research grant support for faculty investigators who have not had prior independent external research grants, to furnish students with high-quality undergraduate and/or graduate research experiences and to enhance the institutional scientifi...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 14, 2024 Category: Research Source Type: funding

Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)
Funding Opportunity PAR-24-144 from the NIH Guide for Grants and Contracts. The SuRE program supports research capacity building at eligible higher education institutions bythrough funding investigator-initiated biomedical research inbasic, social, clinical, behavioral, or translational science that falls in the mission areas of the NIH. The purpose of SuRE awards is to provide research grant support for faculty investigators at resource-limited institutions who are not currently funded by any NIH Research Project Grants (RPGs) - with the exception of SuRE or SuRE-First awards, to furnish students with high-quality und...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 14, 2024 Category: Research Source Type: funding

Utilizing Equipment to Study Environmental Extrinsic Factors and Enhance Rigor and Reproducibility of Animal Research (R24, Clinical Trials Not-Allowed)
Funding Opportunity PAR-24-167 from the NIH Guide for Grants and Contracts. The Office of Research Infrastructure Programs (ORIP) invites grant applications from core facilities, resource centers, animal vivaria, or individual investigators of other shared resources to systematically study the roles of critical environmental extrinsic factors in biological, behavioral, and treatment studies using animal model species, with the objective of enhancing the rigor and reproducibility of animal research. The research area must be broadly applicable to the scientific interests of two or more NIH Institutes or Centers (ICs) and...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 13, 2024 Category: Research Source Type: funding

Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)
Funding Opportunity PAR-24-121 from the NIH Guide for Grants and Contracts. The specific purpose of this NOFO is to promote the development of a diverse, interdisciplinary workforce needed to conduct translational research on Alzheimer's disease and Alzheimer's-related dementias from target discovery through clinical development. This NOFO will support institutional training programs for predoctoral and postdoctoral level researchers with diverse educational backgrounds (i.e., basic biology, translational and clinical research, data science). The program invites eligible institutions to develop interdisciplinary trainin...
Source: NIH Funding Opportunities (Notices, PA, RFA) - March 13, 2024 Category: Research Source Type: funding